This page collects WhisperX intelligence signals tagged #Biologics. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Innovent Biologics has turned its first profit, a milestone achieved just as the competitive landscape for weight-loss drugs in China is set to intensify with the looming arrival of generics. This financial inflection point underscores a critical moment for the biopharma firm, balancing its breakthrough against a futur...
The FDA has delivered a second, decisive rejection to Replimune Group's experimental treatment for advanced melanoma, solidifying the therapy's status as a flashpoint in a high-stakes debate over regulatory standards. This engineered virus, designed to activate the immune system against skin cancer, was initially turne...
The search for a new director of the FDA's Center for Biologics Evaluation and Research (CBER) is not just a hiring challenge—it's a political minefield. Vinay Prasad's brief, tumultuous tenure as acting director has left a legacy of intense external scrutiny, setting the stage for his successor to immediately become a...